|
STOCK OPTIONS AND WARRANTS (Details) (USD $)
|
12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jun. 30, 2013
|
Jun. 30, 2012
|
Nov. 13, 2007
|
Nov. 01, 2004
|
Mar. 04, 2001
|
Jun. 30, 2013
Stock Options [Member]
|
Jun. 30, 2012
Stock Options [Member]
|
Jun. 30, 2009
Stock Options [Member]
|
Jun. 30, 2008
Stock Options [Member]
|
Jun. 30, 2007
Stock Options [Member]
|
Jun. 30, 2006
Stock Options [Member]
|
Nov. 17, 2009
Stock Options [Member]
|
Oct. 27, 2008
Stock Options [Member]
|
Jun. 30, 2013
Stock Options [Member]
Tranche 6 [Member]
|
Jun. 30, 2013
Stock Options [Member]
Tranche 7 [Member]
|
Jun. 30, 2013
Stock Options [Member]
Tranche 8 [Member]
|
Oct. 27, 2008
Stock Options [Member]
Board Members [Member]
Tranche 7 [Member]
|
Nov. 17, 2009
Stock Options [Member]
Board Members [Member]
Tranche 8 [Member]
|
Sep. 25, 2007
Stock Options [Member]
Chief Executive Officer [Member]
|
Jun. 30, 2007
Stock Options [Member]
Board Members, Management Employees and Consultants [Member]
Tranche 6 [Member]
|
Jun. 30, 2008
Stock Options [Member]
Board Members, Management Employees and Consultants [Member]
Tranche 7 [Member]
|
Jun. 30, 2009
Stock Options [Member]
Board Members, Management Employees and Consultants [Member]
Tranche 8 [Member]
|
Jun. 30, 2006
Nonqualified Stock Options [Member]
|
Aug. 06, 2007
Nonqualified Stock Options [Member]
Chief Executive Officer [Member]
|
Jun. 30, 2007
Nonqualified Stock Options [Member]
Chief Executive Officer [Member]
Tranche 5 [Member]
|
Jun. 30, 2013
Nonqualified Stock Options [Member]
Chief Executive Officer [Member]
Tranche 5 [Member]
|
Apr. 18, 2008
Restricted Common Stock [Member]
|
Jun. 30, 2008
Restricted Common Stock [Member]
Consultants [Member]
Tranche 7 [Member]
|
Jun. 30, 2007
Restricted Common Stock [Member]
Board Members, Management Employees and Consultants [Member]
Tranche 6 [Member]
|
Jun. 30, 2013
Warrants [Member]
|
Jun. 30, 2012
Warrants [Member]
|
Jun. 30, 2009
Warrants [Member]
|
Jun. 30, 2008
Warrants [Member]
|
Jun. 30, 2007
Warrants [Member]
|
Jun. 30, 2006
Warrants [Member]
|
Oct. 27, 2008
Warrants [Member]
|
Jun. 30, 2008
Warrants [Member]
Consultants [Member]
Tranche 7 [Member]
|
Jun. 30, 2009
Warrants [Member]
Consultants [Member]
Tranche 8 [Member]
|
Nov. 17, 2009
Warrants [Member]
Consultants [Member]
Tranche 8 [Member]
|
Oct. 27, 2008
Warrants [Member]
Board Members, Management Employees and Consultants [Member]
Tranche 7 [Member]
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||||||||||||||||||||||||
| Number of shares authorized (in shares) | 6,000,000 | 4,000,000 | 3,000,000 | |||||||||||||||||||||||||||||||||||||
| Number of shares vested on grant date (in shares) | 464,102 | 115,428 | 484,056 | 99,977 | 240,302 | |||||||||||||||||||||||||||||||||||
| Number of remaining shares vesting after date of grant (in shares) | 566,357 | 871,000 | 148,571 | 465,000 | ||||||||||||||||||||||||||||||||||||
| Options, weighted average grant date fair value (in dollars per share) | $ 0.48 | $ 0.19 | $ 0.32 | $ 0.46 | ||||||||||||||||||||||||||||||||||||
| Warrants, weighted average grant date fair value (in dollars per share) | $ 0.48 | $ 0.19 | ||||||||||||||||||||||||||||||||||||||
| Term of equity-based payment award | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years | ||||||||||||||||||||||||||||||||
| Shares granted (in shares) | 60,000 | 148,587 | ||||||||||||||||||||||||||||||||||||||
| Fair value assumptions used in estimating fair value of options and warrants [Abstract] | ||||||||||||||||||||||||||||||||||||||||
| Risk-free interest rate (in hundredths) | 3.00% | |||||||||||||||||||||||||||||||||||||||
| Dividend yield (in hundredths) | 0.00% | |||||||||||||||||||||||||||||||||||||||
| Expected volatility (in hundredths) | 91.00% | |||||||||||||||||||||||||||||||||||||||
| Estimated life | 5 years | |||||||||||||||||||||||||||||||||||||||
| Summary of options [Roll Forward] | ||||||||||||||||||||||||||||||||||||||||
| Outstanding at beginning of period (in shares) | 4,083,970 | 4,794,270 | ||||||||||||||||||||||||||||||||||||||
| Granted (in shares) | 0 | 0 | 1,074,666 | 1,335,102 | 681,785 | 1,452,167 | ||||||||||||||||||||||||||||||||||
| Exercised (in shares) | 0 | 0 | ||||||||||||||||||||||||||||||||||||||
| Forfeited (in shares) | (911,153) | 0 | 110,000 | 475,938 | 325,215 | |||||||||||||||||||||||||||||||||||
| Expired (in shares) | 503,080 | (503,080) | (710,300) | |||||||||||||||||||||||||||||||||||||
| Outstanding at end of period (in shares) | 2,669,737 | 4,083,970 | ||||||||||||||||||||||||||||||||||||||
| Exercisable at end of period (in shares) | 0 | 4,083,970 | ||||||||||||||||||||||||||||||||||||||
| Available for issuance at end of period (in shares) | 0 | 0 | ||||||||||||||||||||||||||||||||||||||
| Options, weighted-average exercise price [Roll Forward] | ||||||||||||||||||||||||||||||||||||||||
| Outstanding at beginning of year (in dollars per share) | $ 0.58 | $ 0.57 | $ 0.74 | $ 0.75 | ||||||||||||||||||||||||||||||||||||
| Granted (in dollars per share) | $ 0 | $ 0 | ||||||||||||||||||||||||||||||||||||||
| Exercised (in dollars per share) | $ 0 | $ 0 | ||||||||||||||||||||||||||||||||||||||
| Forfeited (in dollars per share) | $ 0 | $ 0 | ||||||||||||||||||||||||||||||||||||||
| Expired (in dollars per share) | $ 0 | $ 0.82 | ||||||||||||||||||||||||||||||||||||||
| Outstanding at end of year (in dollars per share) | $ 0.60 | $ 0.58 | $ 0.42 | $ 0.20 | $ 0.77 | $ 0.74 | $ 0.75 | |||||||||||||||||||||||||||||||||
| Non-option equity instruments, number of shares [ Roll Forward] | ||||||||||||||||||||||||||||||||||||||||
| Outstanding at beginning of period (in shares) | 947,994 | 974,920 | ||||||||||||||||||||||||||||||||||||||
| Granted (in shares) | 0 | 10,714 | 705,302 | 248,564 | ||||||||||||||||||||||||||||||||||||
| Exercised (in shares) | 0 | 0 | ||||||||||||||||||||||||||||||||||||||
| Expired (in shares) | (13,410) | (37,640) | ||||||||||||||||||||||||||||||||||||||
| Outstanding at end of period (in shares) | 934,584 | 947,994 | ||||||||||||||||||||||||||||||||||||||
| Exercisable at end of period (in shares) | 934,584 | 947,994 | ||||||||||||||||||||||||||||||||||||||
| Equity instruments other than options, weighted-average exercise price [Roll Forward] | ||||||||||||||||||||||||||||||||||||||||
| Outstanding at beginning of period (in dollars per share) | $ 0.48 | $ 0.47 | ||||||||||||||||||||||||||||||||||||||
| Granted (in dollars per share) | $ 0 | $ 0.02 | ||||||||||||||||||||||||||||||||||||||
| Exercised (in dollars per share) | $ 0 | $ 0 | ||||||||||||||||||||||||||||||||||||||
| Expired (in dollars per share) | $ 0.67 | $ 0.96 | ||||||||||||||||||||||||||||||||||||||
| Outstanding at end of period (in dollars per share) | $ 0.36 | $ 0.48 | ||||||||||||||||||||||||||||||||||||||